Ipilimumab

1 Drug classified under this active ingredient

Monoclonal Antibody. Ipilimumab 5 mg/ml.
VIAL (conc. for sol. for I.V. infus.): 10 ml
(50 mg ipilimumb), 40 ml (200 mg
ipilimumb). 3 mg/kg admin. IV over 90
min. every 3 wks. for a total of 4 doses.
Tmt. advanc., unresect./metastat.
melanoma. As monotherapy and in
combination with nivolumab.
C/I: Hypersens.